CRIS Current Research Information System

AVNET, SOFIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.450
AS - Asia 5.107
EU - Europa 4.801
SA - Sud America 353
AF - Africa 340
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 1
Totale 17.084
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.276
CN - Cina 1.741
SG - Singapore 1.493
GB - Regno Unito 1.141
DE - Germania 785
IT - Italia 692
VN - Vietnam 687
SE - Svezia 531
HK - Hong Kong 454
IN - India 269
RU - Federazione Russa 260
BR - Brasile 248
NL - Olanda 229
UA - Ucraina 207
FR - Francia 205
KR - Corea 198
IE - Irlanda 176
CA - Canada 150
FI - Finlandia 107
JP - Giappone 107
CI - Costa d'Avorio 106
AT - Austria 102
ZA - Sudafrica 91
CH - Svizzera 71
TG - Togo 70
EE - Estonia 64
BG - Bulgaria 57
SC - Seychelles 50
AR - Argentina 44
ID - Indonesia 37
BE - Belgio 34
JO - Giordania 33
AU - Australia 31
PL - Polonia 28
ES - Italia 24
GR - Grecia 18
LT - Lituania 17
EC - Ecuador 16
MX - Messico 13
CL - Cile 12
IQ - Iraq 12
PT - Portogallo 12
BD - Bangladesh 11
PE - Perù 11
TR - Turchia 11
NO - Norvegia 7
PK - Pakistan 7
PY - Paraguay 7
CO - Colombia 6
DK - Danimarca 6
MY - Malesia 6
AL - Albania 5
CZ - Repubblica Ceca 5
IR - Iran 5
LB - Libano 5
NG - Nigeria 5
TW - Taiwan 5
DO - Repubblica Dominicana 4
EG - Egitto 4
HR - Croazia 4
HU - Ungheria 4
IL - Israele 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
KE - Kenya 3
KZ - Kazakistan 3
LK - Sri Lanka 3
UY - Uruguay 3
VE - Venezuela 3
ET - Etiopia 2
HN - Honduras 2
MA - Marocco 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
GH - Ghana 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MG - Madagascar 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RW - Ruanda 1
SA - Arabia Saudita 1
SN - Senegal 1
UZ - Uzbekistan 1
Totale 17.084
Salva come PNG Salva come JPEG
Città #
Singapore 1.086
Southend 816
Ashburn 619
Fairfield 600
Chandler 535
Hefei 461
Santa Clara 435
Hong Kong 408
Woodbridge 314
Wilmington 298
Ann Arbor 280
Seattle 278
Houston 255
Princeton 238
Dong Ket 212
Cambridge 200
Beijing 195
Seoul 183
Dublin 175
Boardman 156
Jacksonville 132
Bologna 116
Munich 116
Abidjan 106
Ho Chi Minh City 95
Dallas 92
Tokyo 91
Nanjing 89
Westminster 86
Hanoi 82
Los Angeles 81
Berlin 79
Padova 79
Mcallen 77
Montréal 74
Helsinki 71
Lomé 70
Boston 64
Bern 63
Vienna 63
Saint Petersburg 55
Jinan 52
Sofia 52
Buffalo 49
San Diego 47
Guangzhou 43
Bengaluru 42
Shenyang 42
Milan 39
Redondo Beach 39
Frankfurt am Main 37
New York 37
Windsor 35
Hebei 34
Amman 33
Ottawa 32
Medford 30
Mülheim 29
Nanchang 29
Turin 29
Washington 29
Brussels 28
Florence 28
Hangzhou 28
Bremen 27
Shanghai 27
Des Moines 26
Jakarta 26
Nuremberg 26
Changsha 25
Brisbane 23
Zhengzhou 23
Ha Kwai Chung 22
Toronto 22
Wuhan 22
Tianjin 21
Falkenstein 20
Phoenix 19
Norwalk 18
Redmond 17
Chicago 16
Kuban 16
London 16
São Paulo 16
Turku 16
Warsaw 16
Mahé 15
Moscow 15
Olalla 15
Jiaxing 14
Lappeenranta 14
Tongling 13
Tuscaloosa 13
Da Nang 12
Haikou 12
Paris 12
Pune 12
Redwood City 12
Yubileyny 12
Amsterdam 11
Totale 11.010
Salva come PNG Salva come JPEG
Nome #
The human tumor microbiome is composed of tumor type-specific intracellular bacteria 768
Validation of Suitable Housekeeping Genes for the Normalization of mRNA Expression for Studying Tumor Acidosis 536
Abstract 5909: IDH mutations in G2-3 conventional chondrosarcoma of bone: a mono institutional experience 244
V-ATPase is a candidate therapeutic target for Ewing sarcoma 242
A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate. 220
V-ATPase as an effective therapeutic target for sarcomas. 216
In vitro blockade of Receptor Activator of Nuclear factor kappa b ligand prevents osteoclastogenesis induced by neuroblastoma cells 202
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 197
Exosome-like Nanovesicles Isolated from Citrus limon L. Exert Antioxidative Effect 195
Benign albeit glycolytic: MCT4 expression and lactate release in giant cell tumour of bone 190
Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate 186
Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases. 183
Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway 179
Acid-Induced Inflammatory Cytokines in Osteoblasts: A Guided Path to Osteolysis in Bone Metastasis 176
Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation 174
Prominent role of RAB39A-RXRB axis in cancer development and stemness 168
Cause and effect of microenvironmental acidosis on bone metastases 166
Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles 165
Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Cancer Metabolism 165
The Role of Autophagy in the Maintenance of Stemness and Differentiation of Mesenchymal Stem Cells 165
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 162
The Effects of Systemic and Local Acidosis on Insulin Resistance and Signaling 162
New advances in the study of bone tumors: A lesson from the 3D environment 160
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells. 159
In vitro study of human osteoclast activity on poli(epsilon-caprolactone) as a bone substitute biomaterial 158
MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: A new rationale for the pathogenesis of osteolytic bone metastases 158
Incorporation/Enrichment of 3D Bioprinted Constructs by Biomimetic Nanoparticles: Tuning Printability and Cell Behavior in Bone Models 157
Bone on-a-chip: a 3D dendritic network in a screening platform for osteocyte-targeted drugs 157
Histogenetic characterization of giant cell tumor of bone 155
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience 154
Cathepsin k antisense inhibition of cell polarization and bone resorption in human osteoclast 154
The influence of alumina and ultra-high molecular weight polyethylene particles on osteoblast-osteoclast cooperation 154
Identification and validation of housekeeping genes for gene expression analysis of cancer stem cells 152
Acridine Orange is an Effective Anti-Cancer Drug that Affects Mitochondrial Function in Osteosarcoma Cells 151
Endogenous extracellular matrix regulates the response of osteosarcoma 3D spheroids to doxorubicin 150
Osteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclasts. 150
In vitro effects of an antisense oligonucleotide targeting fgf-2 on renal carcinoma cells metastasizing to bone 149
Tumor-activated mesenchymal stromal cells promote osteosarcoma stemness and migratory potential via IL-6 secretion 149
Exploring metabolic adaptations to the acidic microenvironment of osteosarcoma cells unveils sphingosine 1-phosphate as a valuable therapeutic target 149
Impairment of lysosomal activity as a therapeutic modality targeting cancer stem cells of embryonal rhabdomyosarcoma cell line RD. 146
Increased osteoclast activity is associated with aggressiveness of osteosarcoma. 146
Uncovering the protective role of lipid droplet accumulation against acid-induced oxidative stress and cell death in osteosarcoma 144
Contribution of mitochondrial activity to doxorubicin-resistance in osteosarcoma cells 144
Spheroid-based 3D cell cultures identify salinomycin as a promising drug for the treatment of chondrosarcoma 144
Insulin receptor isoforms are differently expressed during human osteoblastogenesis. 143
3d printing and bioprinting to model bone cancer: The role of materials and nanoscale cues in directing cell behavior 143
Energy metabolism in osteoclast formation and activity 140
The effect of extracellular acidosis on the behaviour of mesenchymal stem cells in vitro 139
Elevated serum activity of TRACP5B in osteosarcoma patients (OS) is associated with an aggressive phenotype and with OS induced osteoclast activity 139
Primitive and bone metastatic renal carcinoma cells promote osteoclastogenesis through endothelial cells 138
Osteoclast differentiation from human blood precursors on biomimetic calcium-phosphate substrates 137
Mesenchymal stromal cell adhesion and proliferation on ion-irradiated and RGD-modified polymer substrates 136
Effects of prelamin A processing inhibitors on the differentiation and activity of human osteoclasts. 134
Pre-clinical Models for Studying the Interaction between Mesenchymal Stromal Cells and Cancer Cells and the Induction of Stemness 134
Role of IGF-IR in osteoclast biology and differentiation 133
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. 133
Serum markers of loosening in patients with THA 132
Acid microenvironment in bone sarcomas 132
Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas 131
Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered lamins. 131
Annual meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic networks in cancer 131
Mesenchymal stroma: Role in osteosarcoma progression 131
Height and pathogenesis of osteosarcoma 130
Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic Adaptations and Targets in Cancer 130
FT-IR Spectral Signature of Sensitive and Multidrug-Resistant Osteosarcoma Cell-Derived Extracellular Nanovesicles 129
Platelet-rich plasma impairs osteoclast generation from human precursors of peripheral blood. 127
Spontaneous Formation of Multinucleated Giant Cells with Bone Resorbing Activity by Long Culture of Human Peripheral Blood CD14-Positive Monocytes In Vitro. 127
Curcumin-loaded nanoparticles impair the pro-tumor activity of acid-stressed msc in an in vitro model of osteosarcoma 127
Oct-1 recruitment to the nuclear envelope in adult-onset autosomal dominant leukodystrophy. 126
Metabolism and microenvironment in cancer plasticity 126
Strawberry-derived exosome-like nanoparticles prevent oxidative stress in human mesenchymal stromal cells 126
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed. 125
Radiodynamic Therapy with Acridine Orange Is an Effective Treatment for Bone Metastases 124
The Effect of Poly(d,l-Lactide-co-Glycolide)-Alendronate Conjugate Nanoparticles on Human Osteoclast Precursors. 124
Cytoskeletal disorganization in human osteoclasts following cathepsin K down-regulation 123
Mesenchymal Stem Cells-Derived Small Extracellular Vesicles and Their Validation as a Promising Treatment for Chondrosarcoma in a 3D Model in Vitro 121
in vitro effects of interferon-alpha on different cellular elements existing in a bone metastasis of renal cell carcinoma 120
IGF2 derived from SH-SY5Y neuroblastoma cells induces the osteoclastogenesis of human monocytic precursors. 120
Individual Trajectories of Bone Mineral Density Reveal Persistent Bone Loss in Bone Sarcoma Patients: A Retrospective Study 119
Stromal cells derived from giant cell tumor of bone show osteoblast-like feature 119
The natural compound Alizarin as an osteotropic drug for the treatment of bone tumors. 118
Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: A cohort study. 116
Automated Detection of Spinal Lesions From CT Scans via Deep Transfer Learning 114
Therapeutic implications of tumor interstitial acidification 114
Photodynamic Surgery for Feline Injection-Site Sarcoma 112
Effects of antisense mediated inhibition of cathepsin K on human osteoclasts obtained from peripheral blood. 111
Perfused Platforms to Mimic Bone Microenvironment at the Macro/Milli/Microscale: Pros and Cons 110
Study on the in vitro effect of platelet rich plasma on bone endothelial cells and on osteoclast differentiation for maxillo-facial surgery 109
Novel histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in sarcoma cancer stem cells 109
Unravelling the Effect of Citrate on the Features and Biocompatibility of Magnesium Phosphate-Based Bone Cements 109
Electrospun fibers coated with nanostructured biomimetic hydroxyapatite: A new platform for regeneration at the bone interfaces 108
Sustained Autocrine Induction and Impaired Negative Feedback of Osteoclastogenesis in CD14(+) Cells of Giant Cell Tumor of Bone 108
A Novel Microfluidic Platform for Personalized Anticancer Drug Screening Through Image Analysis 107
Isolation and characterization of a new cell line from a renal carcinoma bone metastasis 107
MET overexpression turns human primary osteoblasts into osteosarcomas. 106
Sarcoma treatment in the era of molecular medicine 106
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells 106
Antagonizing the S1P-S1P3 Axis as a Promising Anti-Angiogenic Strategy 105
Inhibition of angiogenic activity of renal carcinoma by an antisense oligonucleotide targeting fibroblast growth factor-2. 103
Elevated serum TRACP 5B levels and outcome in osteosarcoma patients 102
Totale 15.261
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.144
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.067 0 0 0 0 0 98 40 185 140 87 60 457
2021/20222.258 200 84 147 165 158 123 58 153 78 237 463 392
2022/20232.358 244 341 129 265 177 177 69 152 371 55 202 176
2023/2024659 81 111 57 51 50 131 27 33 16 54 31 17
2024/20253.187 90 438 216 248 566 199 155 115 30 287 214 629
2025/20263.974 649 745 693 624 1.171 92 0 0 0 0 0 0
Totale 17.501